Question · asked by 0 reviews

Topical triamcinolone acetonide vs Intralesional BCG-polysaccharide nucleic acid (BCG-PSN): Adverse effects

Population
People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Intervention
Topical triamcinolone acetonide
Comparison
Intralesional BCG-polysaccharide nucleic acid (BCG-PSN)
Outcome
Adverse effects

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Topical triamcinolone acetonide vs Intralesional BCG-polysaccharide nucleic acid (BCG-PSN)
Adverse effects · Patients with a clinical and histological diagnosis of symptomatic oral lichen planus (OLP); not concurrently taking…
Interventions for treating oral lichen planus: corticosteroid therapies (2011) · Cochrane All outcomesearlier version CD001168.PUB2, superseded
Xiong 2009: incidence of adverse effects similar in the two groups1 studyGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for treating oral lichen planus: corticosteroid therapies
2020 · Cochrane All outcomes
2019-02Not listedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.